Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

PURPOSE: Due to the burden of COPD in Japan, new pharmacologic treatments are needed to meet patient requirements. This study assessed the efficacy and safety of glycopyrronium (GP) delivered via metered dose inhaler (MDI) in Japanese patients with moderate-to-severe COPD. METHODS: This Phase IIb, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Yasushi, Nakatani, Yuji, Ide, Yumiko, Sekino, Hisakuni, St Rose, Earl, Siddiqui, Shahid, Maes, Andrea, Reisner, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905841/
https://www.ncbi.nlm.nih.gov/pubmed/29695902
http://dx.doi.org/10.2147/COPD.S159246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905841/
https://www.ncbi.nlm.nih.gov/pubmed/29695902
http://dx.doi.org/10.2147/COPD.S159246

Ejemplares similares